Skip to NavigationSkip to content

News

Novartis announces cut to multiple drug research programmes in 2022 full-year report
Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, including their...
Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics
US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.
COVID-19 treatments drive Pfizer’s annual earnings up to $100bn
Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine and antiviral...
Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients
It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer...
>> More News Stories

Features

Veeva la Vida: A Roundup of the R&D and Quality Summit 2022

Pharmafocus journalists Ana Ovey and Lina Adams made their way to Zurich for Veeva’s annual R&D and Quality Summit 2022. Here...

>> More Features

Appointments

Tadashi Maruno

 

Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and President

Hamamatsu Photonics, a leading...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches